參考文獻
［1］衛生部腫瘤防治研究辦公室.中國惡性腫瘤死亡調查研究.北京：人民衛生出版社，1979.
［2］全國腫瘤防治研究辦公室.中華人民共和國惡性腫瘤地圖集.北京：中國地圖出版社，1979.
［3］同濟醫科大學.中國人口主要死因地圖集.北京：中國地圖出版社，1990.
［4］陳君石，柯林?坎貝爾，黎鈞耀，理查德?皮托.中國膳食、生活方式與死亡率——六十五個縣的調查研究. Oxford University Press，Cornell University Press，People's Medical Publishing House，1990.
［5］王隴德：中國居民營養與健康狀況調查報告之一2002綜合報告.北京：人民衛生出版社，2005.
［6］何興舟，楊儒道.室內燃煤空氣污染與肺癌.昆明：云南科技出版社，1994.
［7］尹松年，查德?赫司，李桂蘭，等.苯的流行病學與毒理學研究論文集（II）.北京：中國疾病預防控制中心衛生與中毒控制所出版社，2006.
［8］黎鈞耀.國內外癌癥預防對策和措施研究進展.中華醫學會1985年第二屆全國腫瘤學術會議匯編，天津：1-17，1985.
［9］黎鈞耀.解密我國癌癥歸因，為防控策略導航.中國醫學論壇報腫瘤B6，2012-07-26.
［10］黎鈞耀.癌癥的營養干預研究.化學進展，2013，25（9）：1462-1479.
［11］陳竺.全國第三次死因回顧抽樣調查報告.北京：中國協和醫科大學出版社，2008.
［12］董志偉.中國癌癥研究進展（第七卷）：中國主要癌癥的篩查及早診早治.北京：北京大學醫學出版社，2004.
［13］董志偉.中國癌癥研究進展（第八卷）——中國癌癥高發現場防治工作.北京：北京大學醫學出版社，2007.
［14］張思維，陳萬青，王樂.中國腫瘤登記工作30年.中國腫瘤，2009，18（4）：256-259.
［15］楊文獻.中國林州市食管癌高發區人群病因學預防效果觀察.中國腫瘤，2008，17（7）：548-552.
［16］陳建國.啟東癌癥報告：1972-2011.北京：軍事醫學科學出版社，2013.
［17］游偉程.胃癌流行病學研究進展.中華預防醫學雜志，33：49-51，1999.
［18］袁媛.遼寧省莊河地區胃癌高發現場高危人群綜合防治研究.中國腫瘤，2005，14（5）：3107-3111.
［19］鄭樹，劉希水.我國大腸癌篩檢推薦方案的建立與實踐.中國癌癥研究進展：31-37，北京：軍事醫學科學出版社，2000.
［20］胡宏雷，董時富.幽門螺桿菌感染與胃癌關系的meta分析.中國衛生統計，2006，23（1）：65-67.
［21］陳建國.惡性腫瘤高發現場工作的發展與建議.中國腫瘤，2005，14（5）：294-296.
［22］楊學志，湯勝蘭，廖彩森等.江西靖安縣宮頸癌隊列研究.中華腫瘤雜志，1991，13（6）：409-411.
［23］趙方輝，喬友林.子宮頸癌疫苗研究進展.流行病學進展，2010，12：70-79.
［24］黎鈞耀，布洛特，李冰，等.中國林縣居民癌癥和其他常見病營養預防試驗效果初步報告.中華腫瘤雜志，1993，15（3）：165-179.
［25］曾毅，商銘，劉純仁，等.中國八個省市鼻咽癌病人EB病毒殼抗原的免疫球蛋白的A抗體的測定.中華腫瘤雜志，1979，1（2）：8-11.
［26］曾毅，張蘆光，吳映成，等.廣西梧州市EB病毒IgA/VCA抗體陽性者的追蹤觀察.病毒學報，1985，1（1）：7-12.
［27］李錦添，宗永生.上皮異型性增生和鱗狀化生在鼻咽癌組織發生中關系的探討.中山醫學院學報，1985，6（2）：21-24.
［28］鐘建明，曾毅，廖建等. Epstein-Barr病毒IgA/VCA抗體變動規律和鼻咽癌發病的關系.中華實驗和臨床病毒學雜志，1996，10（3）：225-226.
［29］李蘭娟.感染微生態學研究.公共衛生與預防醫學學科發展報告（2011-2012）. 74-81.北京：中國科學技術出版社，2012.
［30］陳偉，項永兵.體質指數與肺癌關系的流行病學研究進展.中國腫瘤，2009，18（4）：294-297.
［31］Ahn J，Sinha R，Pei Z，et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst，2013，105：1907-1911.
［32］American Society of Clinical Oncology. Accelerating progress against cancer. ASCO's Blueprint for Transforming Clinical and Translational Cancer Research. ASCO，2011.
［33］Belinson JL，Qiao YL，Pretorius RG，et al. Shanxi province cervical cancer screening study：across sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol. Oncol，2001，83，439-444.
［34］Blot WJ，Li JY，Taylor PR，et al. The Linxian Trials：mortality rates by vitamin/mineral intervention group. Am J Clin Nutr 1995，62（suppl）：1424S-1426S.
［35］Chen JG，Egner PA，Ng D，et al：Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China. Cancer Prev Res（Phila）. 2013，6（10）：1038-1045.
［36］Chen T，Yan F，Qian J，Guo M，et al. Randomized PhaseⅡTrial of Lyophilized Strawberries in Patients with Dysplastic Precancerous Lesions of the Esophagus. Cancer Prev Res，2012，5：41-50.
［37］de Villiers EM，Lavergne D，Chang F，et al. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer，1999，81：225-228.
［38］Egner PA，Chen JG，Wang JB，et al. Bioavailability of sulforaphane from two broccoli sprout beverages：results of a shortterm，cross-over clinical trial in Qidong，China. Cancer Prev Res，2011，4：384-395.
［39］Gao Y，Den J，Xiang Y，et al：Smoking，related cancers，and other diseases in Shanghai：a 10-year prospective study. Zhonghua Yu Fang Yi Xue Za Zhi，1999 33：5-8.
［40］Gao YT，McLaughlin JK，Blot WJ，et al：Reduced risk of esophageal cancer associated with green tea consumption. J Natl Cancer Inst，1994，86：855-858.
［41］Gu DF，Kelly TN，Wu XG，et al. Mortality attributable to smoking in China. N Engl J Med，2009，360：150-159.
［42］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 95）：Household use of solid fuels and high-temperature frying/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2006.
［43］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 95）：Alcohol consumption and ethyl carbamate/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2007.
［44］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100B）：Biological agents/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.
［45］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100C）：Arsenic，metals，fibres，and dusts/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.
［46］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100D）：Radiation/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.
［47］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100E）：Personal habits and indoor combustions/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.
［48］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 100F）：Chemical agents and related occupations/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2009.
［49］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 101）：Some chemicals present in industrial and consumer products，food and drinking-water/IARC Monographs Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2011.
［50］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 102）：Non-ionizing radiation，PartⅡ：Radiofrequency electromagnetic fields/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2011.
［51］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 103）：Bitumens and bitumen emissions，and some N-and S-heterocyclic aromatic hydrocarbons/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2011.
［52］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 104）：Malaria and some Polyomaviruses（SV40，BK，JC，and Merkel cell viruses）/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans.
［53］IARC. Monographs on the evaluation of carcinogenic risks to humans（v. 105）：Diesel and gasoline engine exhausts and some nitroarenes/IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC：Lyon，France，2012.
［54］Jian L，Xie LP，Lee AH，Binns CW. Protective effect of green tea against prostate cancer：A case control study in southeast China. Int J Cancer，2004，108：130-135.
［55］Kensler TW，Chen JG，Egner PA，et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthene tetraols in a randomized clinical trial in He Zuo Township，Qidong，PRC. Cancer Epidemiol Biomarkers Prev，2005，14：2605-2613.
［56］Kensler TW，Ng D，Carmella SG，et al. Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong，China. Carcinogenesis，2012，33： 101-107.
［57］King HT，Li JY，Loche FB，et al. Patterns of Site-Specific Displacement in Cancer Mortality among Migrants：The Chinese in the United States. American J Public Health，1985，75（3）：237-242.
［58］Kurmi OP，Arya PH，Lam KBH，et al. Lung cancer risk and solid fuel smoke exposure：a systematic review and meta-analysis. Eur Respir J，2012，40：1228-1237.
［59］Lam KY，He D，Ma L，et al. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Hum. Pathol，1997，28，657-663.
［60］Lan Q，Chapman RS，et al. Household stove improvement and risk of lung cancer in Xuanwei，China. J National Cancer Institute，2002，94（11）：826-835.
［61］Lee SA，Shu XO，Li H，et al. Adolescent and adult soy food intake and breast cancer risk：results from the Shanghai Women's Health Study. Am J Clin Nutr，2009，89：1920-1926.
［62］Leeson N. Potential immune-avoidance mechanism found in RNA virus. Future Virology，2014，9（2）：107-109.
［63］Li B，Taylor PR，Li JY，et al. Linxian nutrition intervention trials：design，methods，participant characteristics and compliance. Annals of Epidemiology，1993，3（6）：577-585.
［64］Li JY，Li B，Blot WJ，et al. Preliminary report on the results of Nutrition Prevention Trials of Cancer and Other Common Diseases Among Residents in Linxian，China. Chinese Medical Journal，1995，108（10）：780.
［65］Yuan JM，Gao YT，Yang CS，et al. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int J Cancer，2007 120：1344-1350.
［66］Li JY，Taylor PR，Li B，et al. Nutrition intervention trials in Linxian，China：multiple vitamin/mineral supplementation，cancer incidence，and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst，1993，85（18）：1492-1498.
［67］Li JY. Preliminary Report on Chemopreventive Trial Effects of Cancer and some Commonly seen Diseases. Monograph of Academic Papers in the 1994 Scientific Annual Meeting（Eds. Scientific Branch of the CAMS and PUMC，Published）：49-60，1994.
［68］Li L，Ji J，Wang JB，et al. Attributable causes of breast cancer and ovarian cancer in China：reproductive factors，oral contraceptives and hormone replacement therapy. Chin J Cancer Res，2012，24：9-17.
［69］Li T，Lu ZM，Chen KN，et al. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis，2001，22，929-934.
［70］Li T，Lu ZM，Guo M，et al. p53 Codon 72 polymorphism（C/G）and the risk of human papillomavirusassociated carcinomas in China. Cancer，2002，95：2571-2576.
［71］Li W，Zhu Y，Yan X，et al. The prevention of primary liver cancer by selenium in high risk populations. Zhonghua Yu Fang Yi Xue Za Zhi，2000，34：336-338.
［72］Liang H，Wang J，Xiao H，et al. Estimation of cancer incidence and mortality attributable to alcohol drinking in china. BMC Public Health. 2010，10：730.
［73］Liu BQ，Peto R，Chen ZM，et al. Emerging tobacco hazards in China：Retrospective proportional mortality study of one million deaths. BMJ，1998，317：1411-1422.
［74］Makar GA，Holmes JH，Yang YX. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst，2014，106（2）：1-8.
［75］Mulcahy N. ASCO adds oomph to breast cancer chemoprevention guide：Will it make any difference? Medscape Medical News. July 8，2013.
［76］Qiao YL，Dawsey SM，Kamangar F，et al. Total and Cancer Mortality After Supplementation With Vitamins and Minerals：Follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst. 2009，101：507-518.
［77］Shiels MS，Pfeiffer RM，Hildesheim A，et al. Circulating Inflammation Markers and Prospective Risk for Lung Cancer. J Natl Cancer Inst，2013，105：1871-1880.
［78］Shu XO，Jin F，Dai Q，et al. Soy food intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev，2001，10：483-488.
［79］Si HX.，Tsao，SW，Poon CS，et al. Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer，2003，103，496-500.
［80］Sperduto RD，Hu TS，Milton RC，et al. The Linxian Cataract Studies：Two Nutrition Trials. Archives of Ophthalmology 111：1246-1253，1993.
［81］Stefanek ME，Andrykowski MA，Lerman C，et al：Behavioral Oncology and the War on Cancer：Partnering with Biomedicine. Cancer Res，2009，69：7151-7156.
［82］Sun CL，Yuan JM，Lee MJ，et al. Urinary tea polyphenols in relation to gastric and esophageal cancers：a prospective study of men in Shanghai，China. Carcinogenesis. 2002，23：1497-1503.
［83］Sun ZT，Chen TY，Thorgeirsson3 SS，et al. Dramatic reduction of liver cancer incidence in young adults：28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis，2013，34（8）：1800-1805.
［84］Thompson PA. Genome-wide Association Studies Meet Chemoprevention. JNCI J Natl Cancer Inst，2013，105（24）：1847-1848.
［85］Tsoref D，Panzarella T，Oza A. Aspirin in Prevention of Ovarian Cancer：Are We at the Tipping Point? J Natl Cancer Inst 106，2014，（2）：1-2.
［86］Visvanathan K，Hurley P，Bantug E，et al. Use of pharmacologic interventions for breast cancer risk reduction：American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol，2013，31：2942-2962.
［87］Wang D，Zheng W，Wang SM，et al. Estimation of cancer incidence and mortality attributable to overweight，obesity，and physical inactivity in China. Nutr Cancer，2012，64：48-56.
［88］Wang JB，Jiang Y，Liang H，et al. Attributable causes of cancer in China. Ann Oncol，2012，23（11）：2983-2989.
［89］Wang JB，Jiang Y，Wei WQ，et al. Estimation of cancer incidence and mortality attributable to smoking in China. Cancer Causes Control，2010，21：959-965.
［90］Wang X，Lin S，Yu I et al. Cause-specific mortality in a Chinese chrysotile textile worker cohort. Cancer Sci，2013，104：245-249.
［91］Xiang W，Shi JF，Li P，et al. Estimation of cancer cases and deaths attributable to infection in China. Cancer Causes Control，2011，22：1153-1161.
［92］Xiao HJ，Liang H，Wang JB，et al. Attributable causes of cancer in china：fruit and vegetable. Chin? J Cancer Res，2011，23：171-176.
［93］Yu SY，Zhu YJ，Li WG，et al. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res，1991，29：289-294.
顧傾城唐時叫什么名字
都市之修真仙帝
吞噬星空之至尊塔
醉纏歡
老兵不死
神級狂婿林凡
大叔不可以
都市狂梟沈清舞陳六合
倚天屠龍之風神傳奇
重生空間之光榮軍屬
［94］Yu SY，Zhu YJ，Li WG. Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res，1997，56：117-124.